These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 590445)

  • 1. Suppression and enhancement of humoral immune response to Toxoplasma gondii by passive antibody.
    Masihi KN; Werner H
    Experientia; 1977 Dec; 33(12):1586-7. PubMed ID: 590445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance to an intracellular protozoan (Toxoplasma gondii) by passively administered antibody.
    Araujo FG; Remington JS
    J Immunol; 1974 Nov; 113(5):1424-8. PubMed ID: 4607763
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of antibody mediated suppression of humoral immune response to Toxoplasma gondii at a cellular level.
    Masihi KN; Werner H
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):405-10. PubMed ID: 848221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma antigen isolated by affinity chromatography with monoclonal antibody protects mice against lethal infection with Toxoplasma gondii.
    Sharma SD; Araujo FG; Remington JS
    J Immunol; 1984 Dec; 133(6):2818-20. PubMed ID: 6491277
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cyclophosphamide on Toxoplasma gondii infection: reversal of the effect by passive immunization.
    Hafizi A; Modabber FZ
    Clin Exp Immunol; 1978 Sep; 33(3):389-94. PubMed ID: 737894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunization protects guinea pigs from lethal Toxoplasma infection.
    Pavia CS; Bittker SJ; Curnick KE
    FEMS Microbiol Immunol; 1992 Jan; 4(2):97-104. PubMed ID: 1547027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii.
    Krahenbuhl JL; Ruskin J; Remington JS
    J Immunol; 1972 Feb; 108(2):425-31. PubMed ID: 5049090
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral evaluation of BALB/c (Mus musculus) mice infected with genetically distinct strains of Toxoplasma gondii.
    Bezerra ECM; Dos Santos SV; Dos Santos TCC; de Andrade HF; Meireles LR
    Microb Pathog; 2019 Jan; 126():279-286. PubMed ID: 30447421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of IgE in immunocompromised rat toxoplasmosis.
    Ridel PR; Auriault C; Darcy F; Pierce RJ; Leite P; Santoro F; Neyrinck JL; Kusnierz JP; Capron A
    J Immunol; 1988 Aug; 141(3):978-83. PubMed ID: 3397537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of Toxoplasma antigens and antibodies in mice infected with different strains of Toxoplasma gondii].
    Lee YH; Kim KY; Kang MS; Shin DW
    Korean J Parasitol; 1995 Sep; 33(3):201-10. PubMed ID: 8528627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
    J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to intracellular parasites: suppression by antibody.
    Araujo FG; Remington JS
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):254-8. PubMed ID: 5007469
    [No Abstract]   [Full Text] [Related]  

  • 14. Strain- and Dose-Dependent Reduction of
    Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
    Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antithymocyte serum on experimental toxoplasmosis in mice.
    Strannegård O; Lycke E
    Infect Immun; 1972 May; 5(5):769-74. PubMed ID: 4539127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
    Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
    Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
    Cui X; Lei T; Yang D; Hao P; Li B; Liu Q
    Vaccine; 2012 Mar; 30(13):2282-7. PubMed ID: 22310204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen.
    Darcy F; Maes P; Gras-Masse H; Auriault C; Bossus M; Deslee D; Godard I; Cesbron MF; Tartar A; Capron A
    J Immunol; 1992 Dec; 149(11):3636-41. PubMed ID: 1431132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
    Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
    BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii.
    Kasper LH; Currie KM; Bradley MS
    J Immunol; 1985 May; 134(5):3426-31. PubMed ID: 3884710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.